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ABSTRACT
The objective of this study was to investigate the biphasic effects of vanadyl
sulfate in cerebral vascular endothelial cells with a focus on understanding the
mechanisms underlying vanadyl sulfate benefits. To first address the effects of
vanadyl sulfate on endothelial permeability, mouse cerebrovascular endothelial
cells were grown to confluence in 96-well electrode ECIS plates and treated with
three different vanadium containing compounds: vanadyl sulfate, vanadium
pentoxide, and ammonium metavanadate. Resistance of the endothelial cell
monolayer was measured at 4kHz for 24 hours for different concentrations of
vanadium containing compounds. The mouse cerebrovascular endothelial cells
were also treated with different concentrations of vanadyl sulfate plus a
superoxide dismutase mimetic, tempol, or a rho kinase inhibitor, fasudil, for 48
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hours to assess oxidative stress and rho kinase activation by vanadium. All three
vanadium-containing compounds exhibited a dose dependent biphasic effect in
resistance. The addition of tempol and fasudil did not increase resistance of
vanadyl sulfate. Additionally, an in vivo mouse study was conducted with two
concentrations of vanadyl sulfate 0.025 mg and 0.25 mg, dosed twice daily for 24
hours. Brain tissue was collected and mRNA transcription levels of intracellular
adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), zona
occludens-1 (ZO-1), occludin and claudin-5 were measured by qPCR. The
transcription levels for the genes of TNF-α and ICAM-1 did not change with
vanadyl sulfate treatment. Blood brain barrier endothelial tight junction protein
occludin transcription levels significantly increased with 0.025 mg vanadyl sulfate
treatment. Levels remained unchanged compared to control for blood brain
barrier tight junction proteins ZO-1 and claudin-5. These studies suggest that
vanadium-containing compounds at certain concentrations may improve the
blood brain barrier. Further investigation of the mechanisms of this effect may
reveal novel therapeutic pathways/targets.
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CHAPTER 1. INTRODUCTION
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Neurotoxicity of Vanadium
Vanadium is a transition metal that is ubiquitous in the environment.
Vanadium is a contaminant of fossil fuels and people can be environmentally
exposed to the metal via crude oil spills and automobile exhaust (Plunkett et al,
1976). Moreover, vanadium is used industrially in the making of pesticides, steel,
and many other materials (Wenning et al, 1988). As such, chronic vanadium
exposure often occurs through environmental or occupational contact (Fatola et
al, 2019). Investigations of vanadium toxicity as well as the potential therapeutic
use of vanadium have linked the heavy metal to tissue remodeling in several
organs including the lungs, testes and liver of rats (Fatola et al, 2019).
Experimental models have also showed vanadium to have neuroinflammatory
effects along with physiologic biochemical changes (Thompson et al, 2009). The
potential therapeutic effects of vanadium have been most substantially studied in
diabetes mellitus, as vanadium has been showed to decrease glucose levels in
diabetic humans (Thompson et al, 2009). A possible mechanism by which
vanadyl sulfate leads to decreased glucose levels is through the up-regulation of
PI3-kinase, which phosphorylates IRS-1 leading to increased inhibition of
glucagon (Goldfine et al, 2000). Additional diseases where vanadium has been
studied for therapeutic benefits include syphilis, hyperlipidemia, tuberculosis,
anemia and malnutrition (Fatola et al, 2019). When thinking about the toxicity or
therapeutic benefits of vanadium it is essential to understand that the
downstream effects of vanadium exposure are dependent on dose, route of
exposure and valance state (Madejon et al, 2013). As industrial applications of
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vanadium continue to increase and the extent of environmental exposure
becomes more evident, there is an emerging need for deeper investigations into
the physiological role and mechanisms of action of vanadium to better
understand its possible therapeutic effect and levels that lead to toxicity.
Several studies have been conducted in rodent models to understand the
toxicity of vanadium in the brain (Fatola et al, 2019).In a chronic mouse model of
exposure, metavanadate vanadium injected intraperitoneally (IP) (3mg/kg/day
three times a week for 3-18 months) was found to cross the blood-brain barrier,
as assessed by laser ablation inductively coupled plasma-mass spectrometry
(Folarin et al, 2017). Vanadium accumulation was observed throughout the brain,
with higher concentrations found in the olfactory bulb, cerebellum and brain stem.
Moreover, mice exposed to vanadium had histological lesions in the pre-frontal
cortex and a significant decrease of neurons in the hippocampus (Folarin et al,
2017). In another study, the effect of chronic (90 day) vanadium exposure in
early life was assessed using a mouse model (Azeez et al, 2016). In this model,
pups were exposed to sodium metavanadate via lactating dams injected IP with
3mg/kg of vanadium for the first 21 days. For the remaining exposure time frame,
the weaned mice received 3mg/kg IP vanadium three times per week via IP
injections. Early life exposure to vanadium resulted in deteriorating myelin tracts
in the thalamus, hippocampus, and different layers of the cortex. Moreover,
exposure animals exhibited increased levels of astrocyte-expressed tumor
necrosis factor alpha (TNFα) (Azeez et al, 2016).
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The most common form of human environmental exposure to vanadium is
via inhalation. In an inhalation study, mice were exposed to 0.02 M vanadium
pentoxide for 1 hour two times a week for 4 weeks total using an acrylic chamber
(Colin et al, 2015). Mice had a decrease in olfactory bulb size, swollen
organelles, and mitochondrial dysregulation Colin et al, 2015). In a similar
inhalation study with vanadium pentoxide, mice were exposed to 0.02M
vanadium pentoxide for 1 hour twice a week via a nebulizer for 8 weeks resulting
in loss of cilia of ependymal cells in circumventricular organs of the brain and
oxidative damage in the choroid plexus (Avila-Costa et al, 2005).
Various mechanisms for vanadium neurotoxicity have been reported. One
of the major proposed mechanisms for vanadium neurotoxicity is the production
of reactive oxygen species (Fatola et al, 2019). When vanadium is in the blood is
typically in +5 oxidation state in a pH range of 4-8 pH (Nechay et al, 1984).
Vanadium can enter cells in the form of vanadate through anion channels and it
can also enter cells as vanadyl ions through the process of passive diffusion.
When vanadate is in the cytoplasm it is converted to vanadyl, a reduction leading
to the production of reactive oxygen species (Ding et al, 1994). Vanadyl can then
be converted to vanadate via hydrogen peroxide by Fenton-like reactions. This
oxidation reaction can also lead to the production of free radicals (Figure 1)
(Capella et al, 2002). In another study, rats exposed intratracheally to 0.5 mL of
1.0 mM vanadyl sulfate over a 24-hour period had increased levels of free
radicals in the lung as detected by electron spin resonance (Kadiiska et al,1997).
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Figure 1. Mechanism of vanadium produced intra-cellular toxicity. Vanadium
enters the cell typically in the +5 valence state and is converted to the +4 state by
NADPH oxidation inside the cell. The conversion of vanadium +4 to +5 can
produce oxygen radicals and hydrogen peroxide. Vanadium +4 can form a
reaction with hydrogen peroxide to make hydroxyl particles. (Figure based on
Capella, L. et al., 2002).

At high intracellular doses, vanadium can promote oxidative stress (Figure 1)
and, owing to the high lipid content in the brain, such reactions can lead to lipid
peroxidation affecting the myelin of neurons (Todorich et al, 2011).
Another proposed mechanism of vanadium neurotoxicity is through
binding to protein phosphorylation enzymes. For example, vanadate has the
capacity to bind to cysteine residues in proteins and, as a consequence, the
complex can react with hydrogen peroxide to form pervanadate ions that can
consequently oxidize the cysteine residues (Fatola et al, 2019). Cysteine
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residues are located in active sites of several proteins such as protein
tyrophosphatase, which can be inactivated by vanadate. Inhibition of protein
phosphorylation results in sustained activation of specific intracellular pathways,
including, for example, the MAPK cascade which plays a major role in
inflammatory cytokine activation (Chien et al, 2006).
Vanadium may also exhibit possible therapeutic effects in different
disease states. There does seem to be a threshold for toxicity and at low enough
doses vanadium does not appear to cause overt toxicity. Bis(ethyl maltolato)
oxido vanadium (BEOV) is an antidiabetic agent that is clinically being tested
(Domingo and Gomez et al, 2016). In addition, the use of vanadium has been
proposed to treat various forms of cancer as well as viral and bacterial diseases
(Rehder et al, 2016). Low doses of vanadium have the potential to promote
positive therapeutic effects, however the administration of such doses over an
extended period of time should be avoided as it can lead to the development of
tumors (Korbecki et al, 2012). Interestingly, vanadium has been reported to have
a biphasic effect in osteoblast cells. Depending on the dose of vanadium, it can
have cell proliferation and differentiation effects or it can induce inhibition of cell
proliferation (Cortizo et al, 1995). This is likely related to a hormetic effect that
switches from low doses that target disease pathways to higher doses that are
potentially toxic due to oxidative effects. Recent work by (Dyer et al, 2015)
suggests that vanadium has a beneficial effect in cognition in rats exposed to
vanadium through their food for four weeks. However, while several studies
explore the effects of vanadium at a high dose, there is a significant gap in
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knowledge regarding the possible effects and mechanisms of action of low dose
vanadium exposure on the brain (Fatola et al).

Blood-brain Barrier Cell-Cell Junctions
The blood-brain barrier (BBB) protects the major regions of the brain from
the environment by providing a more controlled transport of molecules to and
from the brain parenchyma. The BBB is found in the arteries and veins
throughout the brain excluding circumventricular organs and is composed of
specialized endothelial cells. Cerebral vascular endothelial cells are distinctive
from endothelial cells outside of the nervous system. Brain endothelial cells have
tight junctions that resemble epithelium cells that tightly regulate the solutes
allowed to reach the brain by passive diffusion. Additionally, cerebral endothelial
cells have specialized transporters that also regulate what nutrients can reach
brain tissue. Similar to the peripheral endothelial cells, brain endothelial cells are
also charged and have specific transporters that are able to inactivate toxic
substances and efflux the toxic chemicals away from the brain. As a result of
endothelial tight junctions and specialized transporters, plasma contents are
closely regulated, thereby protecting brain cells from possible harmful plasma
solutes. Other specialized characteristic of brain endothelial cells is that they
contain a high number of mitochondria to account for the high metabolic work
that endothelial cells perform. In addition, endothelial cells lack fenestrations and
have limited pinocytosis thereby decreasing transcellular transport (Cipolla et al,
2009).
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The BBB is composed of adherens and tight junctions that connect cells
paracellularly. The tight and adherent proteins connect to adapter proteins and
these proteins connect to actin and the cytoskeleton of the cells. Several
neurological disorders can cause tight junction dysregulation and BBB
impairment, including: Alzheimer’s disease, ischemic stroke, Parkinson’s
diseases, multiple sclerosis, hypertension, and seizures (Zlokovic et al, 2008).
Strategies to improve BBB function in such diseases may be beneficial to reduce
neuroinflammation and better support cognitive function.
Tight junctions are made up of transmembrane proteins that include:
claudin, occludin, junction adhesion molecules (JAM), and zona occludens
(Cipolla et al, 2009). Claudins account for the majority of the BBB junction
proteins with more than 20 identified claudin proteins (Morita et al,1999). Claudin
tight junction proteins connect with zona occluden (ZO) proteins ZO-1, ZO-2, and
ZO-3 on their carboxyl terminus in the cytoplasm. ZO-1 and ZO-2 connect with
the cytoskeleton via actin proteins in their carboxy-terminus (Furuse et al,1999).
Claudin proteins, in conjunction with different zona occludens, cingulin proteins
and several other proteins,provide support to tight junctions (Citi et al, 1988).
Occludin proteins also make up tight junctions in cerebral endothelial cells.
Occludin proteins are transmembrane proteins that have amino and carboxyl end
terminus in the cytoplasm. Occludins and claudins both have two extracellular
proteins that form bonds with their neighboring cells occludins and claudin
proteins making paracellular connections and forming part of the BBB (Cipolla et
al, 2009). The occludin proteins form a direct link with zona occluden proteins
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that form a link with actin and the cytoskeleton. Therefore, occludin proteins are
able to regulate the passage of solutes in close coordination with the
cytoskeleton (Mitic et al, 2000). Junction adhesion molecules (JAM) are also
membrane proteins that form tight junctions with ZO-1. There have been a total
of three identified junction adhesion molecules (JAM): JAM-1, JAM-2 and JAM-3.
Of these three proteins only JAM-1 and JAM-3 are found in the endothelium
tissue of the brain. JAM-1 is found with actin and is subsequently involved in
paracellular adhesion (Aurrand-Lions et al, 2001). Besides playing a structural
role in connecting claudins, occludins and junction adhesion molecules to the
cytoskeleton, ZO proteins are also involved in signaling molecules by PSD95/Discs large/ZO-1 (PDZ) and SRC homology 3 domains (Yuan, Rigor et al,
2010).
Adherent junctions also form the ultrastructure of the BBB. Adherent
junctions in the cerebral endothelium are made from vascular endothelial
cadherin proteins that from hemotypic bonds with other vascular endothelial
cadherin proteins from adjacent cells. Vascular endothelial cadherin proteins are
connected to beta or gamma catenin proteins that are connected to alpha catenin
that, in turn, is connected to actin filaments and the cytoskeleton (Figure 2; Yuan,
Rigor et al, 2010).
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Figure 2. Tight junction protein structure of endothelial cells in the blood-brain
barrier. Occludin, claudin and JAMA proteins form bonds intracellular with ZO
proteins and extracellular with each other forming a selective barrier. Figure
based on (Yuan SY, Rigor RR, 2010).

Blood-Brain Barrier Dysfunction
BBB dysfunction typically leads to an increase in the traffic of molecules
paracellularly or transcellularly, in a way that exposes the brain to factors
normally absent. For example, BBB dysfunction occurs if there is an increase in
pinocytic activity or if a large flux of molecules opens the tight junction proteins.
BBB integrity is compromised in several neurological conditions including stroke,
stress, multiple sclerosis. What all the above conditions have in common is the
production of reactive oxygen species (ROS), has been implicated in BBB
impairment (Pun et al, 2009). Experiments in frogs have showed a relationship
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between amplified levels of reactive oxygen species and BBB permeability
(Olesen et al, 1987). Several findings indicating the pathways by which reactive
oxygen species lead to BBB disruption have been reported. One of those
pathways is through the bradykinin system (Pun et al, 2009). Bradykinin levels
increase in the brain when there is ischemia and reperfusion (Kamiya et al,
1993). Bradykinin has been linked to the activation of phospholipase A2 which is
able to cut membrane phospholipids and subsequently releases arachidonic
acid. Arachidonic acid is metabolized and produces reactive oxygen species that
affect the integrity of the BBB (Pun et al, 2009). Neutrophils are white blood cells
that get activated in the presence of inflammation. When there is ischemia,
neutrophils are recruited to the injured site and start to increase the generation of
superoxide molecules (Pun et al, 2009). Macrophage accumulation has also
been implicated in the generation of reactive oxygen species when there is insult
to the brain. Macrophages recruit pro-inflammatory factors such as TNF-α and
early growth response protein (Egr-1), which have been implicated in blood-brain
barrier disruption (Lynch et al, 2004). The depletion of glutathione levels has
been correlated to increased levels of oxidative stress. Oxidative stress caused
by low levels of glutathione is produced when proteins like sulfhydryls are left
vulnerable to oxidative attack (Hall et al, 1997). Changes in tight junctions, as
mentioned earlier, have been linked to changes in barrier integrity. Similarly,
exposure of xanthine/xanathine oxidase reduces protein levels of the tight
junction protein occludin. In addition, hydrogen peroxide leads to increased levels
of occludin and, interestingly, occludin is found at the cell membrane and not

11

necessarily at the tight junctions (Pun et al, 2009). Similar to tight junctions, the
cytoskeletal plays a vital role in blood-brain barrier integrity. The production of
reactive oxygen species can cause changes in the cytoskeleton. For example,
reactive oxygen species can cause the activation of Rho phosphorylates which,
in turn, activate proteins such as rho-associated protein kinase (ROCK), focal
adhesion kinase (FAK) and mDIA (Pun et al, 2009). When proteins such as
(ROCK) get activated, myosin light chain proteins are phosphorylated causing
structural changes to the cytoskeleton, particularly by actin proteins. Increased
levels of ROS/RNS including peroxide, peroxynitrite (ONOO-) and nitric oxide
(NO), also phosphorylate tight junction proteins such as occludin and cause
changes in cytoskeletal organization (Haorah et al, 2005). The phosphorylation of
various proteins in the cytoskeletal and tight junctions leads to rearrangement of
the cytoskeleton and an increase in blood-brain barrier permeability (Pun et al,
2009).
Matrix metalloproteinases (MMP) are capable of breaking down proteins
from the extracellular matrix and basement membrane into amino acids .The
activation of MMPs leads to an increase in blood-brain barrier permeability. One
possible mechanism by which MMPs disrupt blood-brain barrier integrity is by
decreasing levels of the tight junction protein occludin and preventing the
development of an endothelial gap (Reijerkerk et al, 2006). The specific
activation of MMP’s is not known but studies have shown that protein tyrosine
kinase inhibitors can decrease levels of MMP’s (Haorah et al, 2007). The
activation of protein tyrosine kinase is believed to increase under oxidative stress
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leading to increase barrier integrity dysfunction (Pun et al, 2009). Inflammatory
mediators have also been well studied in the disruption of the BBB. Reactive
oxygen species can active the transcription factor NF-kB and this transcription
factor promotes the activation of adhesion molecules including intracellular
adhesion molecule-1 (ICAM-1) and vascular cell adhesion protein 1 (VCAM-1)
(Kim et al, 2008). ICAM-1 activates calcium dependent signaling pathways and
makes modifications to the blood-brain barrier. The adhesion molecules are
known to promote the recruitment of white blood cells such as neutrophils and
leukocytes. Recruitment is thought to be rho dependent and the white blood cells
can release inflammatory mediators such as TNF-α and IL-1 beta that can
damage the BBB. Not only are the mediators causing damage to the BBB, but
also the movement of cells across the membrane can cause further endothelial
barrier damage by decreasing occludin levels. Additionally, neutrophils and
macrophages cause an increase in reactive oxygen species further contributing
to endothelial barrier dysfunction (Pun et al, 2009). All together, reactive oxygen
species can create blood-brain barrier disruption by activating different proteins
and pathways (Zlokovic et all, 2008).
Cerebrovascular Disease, Stroke, and the Blood-brain Barrier
BBB structure and dysfunction is a prominent pathologic factor in many
diseases such as stroke. Stroke attributed to 16.9% of all cardiovascular deaths
in 2016. Hospitalizations due to stroke have also increased by approximately
40% from 2003 to 2012. Patients with a higher risk of stroke include those who
suffer from high blood pressure, obesity, high blood glucose levels,
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hyperlipidemia and kidney dysfunction. Other risk factors contributing to stroke
include life-style choices such as smoking, living a sedentary lifestyle and not
consuming healthy foods. Also, a global risk contributing to stroke is air pollution,
adding a 29% increased risk (Benjamin et al, 2019). Stroke can occur through
several different mechanisms. Two of the most common types of stroke are
ischemic and hemorrhagic. In ischemic stroke there is a blockage in the blood
vessels that prevents normal blood flow typically caused by a blood clot. In a
hemorrhagic stroke, blood vessels become weak and rupture leading to
decreased blood flow to the brain. During an ischemic stroke the BBB is
disrupted and starts to leak due to an increase in MMP’s, inflammatory factors,
oxidation pathways, and disruption in junction-junction and junction-cytoskeleton
interactions (Sifat et al, 2017). The available treatments for an ischemic stroke
are limited and include tissue type plasminogen activator (tPA) and
thrombectomy in certain patient populations, which function to remove clots. The
Food and Drug Administration has not approved any neuroprotective or
neurorestorative treatments for acute ischemic stroke. New treatments are
warranted to decrease neuronal death (Sifat et al, 2017).
The phosphorylation of tight junction proteins such as occludin, claudin-5
and ZO-1 by factors such as cyclic AMP, Rho/ROCK kinases and vascular
endothelial growth factor have been reviewed over the years (Jiang et al, 2018).
In stroke models, phosphorylation of tight junctions and an increase in BBB
permeability is typically induced and results from several inflammatory factors. In
cultured brain cells, biomolecules such as cytokines including TNFα , interleukin-
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6, and monocyte chemoattractant protein 1 can promote phosphorylation of the
tight junction protein ZO-1 (Jiang et al, 2018). When endothelial cells are cultured
with monocytes, Rho kinases become activated and subsequently phosphorylate
occludins and claudin-5 leading to increased ability of white blood cells to cross
the BBB (Persidsky et al, 2006). Controlling the changes in tight junction protein
integrity in stroke disease is important. Many studies have focused on the
phosphorylation changes of tight junction proteins, but the proteins can also
undergo other structural modifications such as methylation, acetylation, or
ubiquitination, which have not been studied as extensively (Jiang et al, 2018).
Tight junction proteins can translocate depending on the regulatory
biochemical environment. Studies have demonstrated the translocation of tight
junction proteins occludin and claudin-5 when endothelial brain cells are exposed
to C-C Motif Chemokine Ligand 2 (CCL-2) resulting in a decreased TEER
(Stamatovic et al, 2009). Another approach that can result in the translocation of
tight junction proteins after an ischemic stroke event is within the cytoskeleton.
The cytoskeleton in ischemia can undergo changes resulting in actin
polymerization and alterations that can lead to tight junction proteins moving to
the cytoplasm. The cell-to-cell adhesion is reduced and the junction proteins can
more easily become degraded. Preventing negative cytoskeletal changes can
prevent tight junction protein translocation and changes leading to negative
barrier integrity (jiang et al, 2018). Several studies have tried to improve the BBB
by different pathways. In one of the pathways, steroids are given to try and
decrease inflammatory factors (Jiang et al, 2018). In another study, to decrease
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the phosphorylation of tight junction proteins, rho kinase inhibitor fasudil was
given to mice after transient middle cerebral artery occlusion and fasudil inhibited
BBB disruption (Jiang et al, 2018). While other studies have used lentivirus to
over express tight junction protein claudin-5 in retinal endothelial cells leading to
an enhance in barrier integrity (Jiang et al, 2018).
Tight junction proteins are not only affected by phosphorylation and
translocation, but they can also be degraded by (MMP’s). Such proteins are
activated by zinc, which is increased in events such as ischemic stroke (Rempe
et al, 2016). Zinc is able to activate MMP-9 and MMP-2, which consequently
decrease the levels of occludin and claudin-5. After a stroke, MMP-9 and MMP-2
levels remain high, leading to decreased function of tight junction proteins and an
increase in blood-brain barrier integrity (Jiang et al, 2018). In a stroke, endothelial
cells have to react to ischemia and hypoxic conditions. As stated above, the
cytoskeleton starts to rearrange and tight junction proteins start to degrade. In
addition, during a stroke, endothelial cells have to deal with oxidative stress and
inflammation leading to an increase in neutrophil infiltration, MMP’s, inflammatory
cytokines leading to autophagy (Jiang et al, 2018). There are many regulators of
the BBB, some of which are activated by stressors such as stroke and lead to
further damage and other chemicals that are activated help to restore the BBB
integrity. Chemicals that have been reported to negatively influence the BBB
include inflammatory cytokines TNF-α , interleukin-6 (IL-6), interleukin-1 (IL-1),
bradykinin, histamine, thrombin, nitric oxide, glutamate, and free radicals (Johann
et al, 2013).
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As mentioned earlier, there are many risk factors for the development of
stroke, including but not limited to hypertension, hyperglycemia and
hyperlipidemia (Benjamin et al, 2019). These diseases can cause functional and
structural changes in the blood-brain barrier (Benjamin et al, 2019). Animal
studies that include the use of spontaneous hypertension rat models have shown
BBB dysfunction in the cerebral cortex at five months and hippocampus BBB
dysfunction at 3 months (Jiang et al, 2018). Spontaneous hypertensive rat
models are similar to essential hypertension in humans (Jiang et al, 2018). In
renal hypertensive rats, 8-weeks of hypertension results in changes to
endothelial tight junctions (Fan et al, 2015). Tight junctions such as occludin and
ZO-1 levels were significantly lower at 8-weeks and also gradually decreased
over time (Fan et al, 2015). When hypertension in rats is induced by constricting
the aorta, the gene expression of the tight junction proteins claudin-3 and
claudin-5 is decreased (Mohammadi et al, 2014). In addition, in spontaneously
hypertensive rats, pro-inflammatory factors such as IL-1b and TNF-α levels are
increased (Tayebati et al, 2016). TNF-α expression levels were high in the
frontal cortex of the hypertensive rats (Tayebati et al, 2016). Furthermore,
acutely-induced hypertensive rat models have an increase in oxidative stress
(Poulet et al, 2006).Transverse aortic coarctation done between the two carotid
arteries in rats leads to hypertension and an increase in nicotinamide adenine
dinucleotide phosphate (NADPH) oxidase enzyme activity 1 day after
hypertensive surgery. One and seven days after the surgery, albumin
extravasation increased in the surgery rats compared to the sham-operated rats
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in the hippocampus and the cortex indicating BBB damage (Poulet et al, 2006).
These studies highlight the importance of controlling high blood pressure in
patients to prevent BBB damage.
Diabetes is another disease that has the potential to damage the
enodothelial BBB. Studies indicate that hyperglycemia leads to a decrease in the
tight junction proteins occludin, claudin and ZO-1. Hyperglycemia increases the
oxidative stress that leads to a decrease in tight junction proteins. Hyperglycemia
in numerous studies has been related to an increase in BBB permeability and
increase rate of mortality (Jiang et al, 2018). Diabetic mice brain periventricular
regions exhibit increased BBB permeability measured by albumin leakage
(Fujihara et al, 2016). In other studies conducted in 40-weeks old diabetic rats
exposed the damage of untreated diabetes in the BBB. Rats displayed a
decrease in the protein levels of occludin and claudin-5 in the hippocampus (Yoo
et al, 2006). In other rat model studies of induced hyperglycemia and brain
ischemia, enhanced BBB disruption is evident. The hyperglycemia rats
demonstrated greater barrier disruption early after artery occlusion compared to
a longer time frame of ninety minutes. This evidence suggests that patients with
high blood glucose levels should be treated immediately when having a stroke
(Ennis et al, 2007).
Thus, impaired BBB is intimately related to the severity of outcomes in
stroke and other related diseases. Therapeutic strategies to improve BBB
integrity in stroke models have led to limitations of cerebral necrotic regions and
overall improvements in neurocognition (Sifat et al, 2017). Conversely,
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environmental stressors may have an important role in exacerbating BBB
impairment therefore compounding the effects of stroke.
Summary and Research Objectives
The purpose of this study is to investigate dose-dependent toxicologic and
therapeutic effects of vanadium sulfate in the permeability of the BBB with a
focus on the therapeutic benefit in murine cerebral vascular endothelial cells and
animal studies. As exposure studies have noted a seeming threshold of toxicity
from systemic vanadium, we posit that there may be a hermetic effect of
vanadium on endothelial cell function, permitting a potential therapeutic window
for improvement in cell-cell interactions and overall barrier integrity.
Thesis objectives:
1. Investigate vanadium sulfate dose dependent BBB permeability.
2. Evaluate vanadium sulfate mechanism of oxidative stress and
inflammatory factors in the BBB.
3. Characterize the effect of vanadium sulfate in BBB tight junctions.
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Chapter 2. Biphasic effects of vanadium sulfate on
cerebrovascular endothelial cell barrier integrity.
Introduction
Vanadium is a transition metal that can readily be found in the
environment and reflects a potential environmental and occupational exposure
risk for many. While it has not been extensively studied, there are numerous
reports of systemic vascular toxicity of vanadium. Vanadium has been shown to
cross the BBB and such exposure leads to lesions in different parts of the brain
including layers of the cortex (Folarin et al, 2017) In combination with structural
changes in the brain, vanadium can also lead to an increase in pro-inflammatory
factors such as TNF-α (Azeez et al, 2016) and oxidative stress (Avila-Costa et
al, 2005). In addition to having a toxicological effect, vanadium has been reported
to have therapeutic effects, albeit at lower concentrations. Vanadium-containing
compounds have been used as a diabetic treatment compound leading to
decrease levels of glucose (Domingo and Gomez et al, 2016). Additionally,
Vanadium (IV) and vanadium (V) have been shown to counteract reactive
oxygen species through the generation of a superoxovanadium complex, which
transforms ROS to oxygen molecules by superoxide oxidation (Kelm et al, 2001).
In a recent study, rats exposed to vanadium via food mash containing vanadium
0.05mg/1g showed cognitive improvement compared to control rats who received
no vanadium in their diet (Dyer et al, 2015). A gap in knowledge exists of the
possible beneficial or harmful effects of vanadium in the brain, in terms of
dosage, valence states, and mechanism of action (Fatola et al, 2019).
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The BBB is composed of specialized cell-cell junctions. In the brain,
endothelial cells have tight junctions similar to epithelial cells. The tight junctions
play a critical role in regulating the solutes that are able to reach the cells of the
brain. The tight connection between brain endothelial cells confers an electrical
resistance of the BBB approximately 1500-2000 Ω-cm^2 (Cipolla et al, 2009).
The endothelial barrier is composed of transmembrane tight junction proteins.
Tight junction proteins include but are not limited to claudin, occludin and zona
occludens (Cipolla et al, 2009). Claudin proteins connect with zona occluden
proteins in the cytoplasm and the zona occludens proteins connect to the
cytoskeleton via connection to actin proteins (Furuse et al,1999). Occludin
proteins also connect with zona occluden proteins that connect to the
cytoskeleton by binding to actin; in this way occludin tight junctions are able to
regulate the passage of solutes in close relationship with the cytoskeleton (Mitic
et al, 2000). Tight junction proteins occludin and claudin have two extracellular
proteins that form bonds with the extracellular occludin and claudin proteins of
neighboring cells (Cipolla et al, 2009). Such proteins connect brain endothelial
cells paracellular and regulate passage of solutes arising from the circulatory
system.
The BBB can be disrupted when there is an increase in paracellular or
transcellular traffic, which can cause the tight junctions to open. Cerebrovascular
events such as stroke cause disruption of the BBB and one of the mechanisms of
barrier disruption is by the generation of reactive oxygen species (Pun et al,
2009). During ischemia, neutrophils get activated by inflammation processes.
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The recruitment of neutrophils leads to an increase in the generation of reactive
oxygen species (Pun et al, 2009). Macrophages can also be activated when
there has been an insult to the brain. These white cells can recruit proinflammatory factors such as TNF-α, which can negatively affect BBB (Lynch et
al, 2004). Changes in endothelial brain barrier tight junctions can also lead to
barrier disruption. Studies have demonstrated that when claudin-5 junction
proteins are exposed to ONOO-, the tight junction protein levels decrease
leading to brain permeability similar to when occludin proteins are exposed to
hydrogen peroxide. Similar to tight junction dysfunction, reactive oxygen species
can also disrupt the cytoskeleton. ROS activates rho phosphorylates that in turn
activate proteins like ROCK (Pun et al, 2009). When the protein ROCK gets
activated, myosin light chains get phosphorylated provoking structural changes in
the cytoskeleton (Haorah et al, 2005). Reactive oxygen species can also activate
transcription factors that activate ICAM-1 and VCAM-1 (Kim et al, 2008). These
adhesion molecules recruit white blood cells, which can damage the BBB by
activation of inflammatory mediators (Pun et al, 2009).
In this study, we propose that vanadium sulfate may be a possible
therapeutic option when used in low doses. We show that low vanadium doses
are not toxic to cerebral vascular endothelial cells and such doses have a
potential benefit in increasing electrical BBB permeability. We also demonstrate
by animal studies that vanadium does not alter transcription levels of tight
junction proteins but increases occludin tight junction protein translation. Our
results indicate that vanadium, at optimal doses, can have therapeutic effects.
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Identification of the mechanisms of action could potentially be applied to
diseases such as stroke when the integrity of the BBB is disrupted.

Materials and Methods
Electric Cell-substrate Impedance Sensor (ECIS)
Mouse cerebral vascular endothelial cells were used to assess electrical
resistance. The electric cell impedance sensing system was used to determine
the changes in BBB integrity. A monolayer of cerebral vascular endothelial cells
was placed in each well. Approximately 5x105 cells were placed in each well and
the cells were grown to confluence demonstrated by a plateau line in resistance.
After the cells reached an electric plateau state, the media of the endothelial cells
was replaced with media containing different experimental treatments. As soon
as the different treatments were added, the resistance of the cells was measured
at 4kHz for 24 hours. All treatment groups were run in triplicates. All treatment
groups were then compared to the media-only control groups or to doseequivalent groups in the case of pharmacological treatments. ECIS at 4kHz
measures transcellular electrical current flow of endothelial cells.
In Vivo Vanadium Exposure
A total of three groups of C57BL6/J male mice (Taconic Laboratories) were
utilized for this study (n=5/gp). Upon arrival to our laboratory at 6 weeks old mice
acclimated for one week under AAALAC-approved housing conditions (12h
light:12 hr dark cycle, 21-25°C, food and water available ad libitum). After the
acclimation, mice were divided into the following groups: saline 0.9%, vanadyl
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sulfate 1 mg/kg (low dose), and vanadyl sulfate 10mg/kg (high dose). Vanadyl
sulfate was dissolved in 0.9% isotonic saline solution. The injection volume was
100µL with a vanadyl sulfate high concentration of 0.25 mg
vanadyl sulfate/100µL and a vanadyl sulfate low concentration of 0.025mg
vanadyl sulfate/100µL. The mice were exposed to one dose of vanadyl sulfate
and another dose 12 hours after the initial dose. Vanadyl sulfate was
administered via intraperitoneal injections under isoflurane anesthesia. After 24
hours the mice were anesthetized with isoflurane and euthanized. Brain tissue
was harvested by doing a vertical midline cut starting at the nape of the neck to
the tip of the nose using sterile microscissors and forceps. The brains were then
instantly frozen in liquid nitrogen. All procedures were approved by the University
of New Mexico Institutional Animal Care and Use Committee.
RNA Extraction from Brain Tissue
RNA was extracted from the frontal cortex of mice exposed to both
concentrations of vanadyl sulfate as well as control animals. Lysis buffer was
added to tubes containing the isolated brain cortex and the tissue was
homogenized using beads for 1 minute. Shredders and RNeasy columns and
collection tubes were labeled and used for each sample. The homogenized
tissue was then added to the shredder tubes and centrifuged for 2 minutes at
10,000 RPM. Tissue was then transferred to RNeasy columns and centrifuged
for 30 seconds at 10,000 RPM. Different buffers including buffer RW1 and buffer
RPE were used to extract the RNA. RNase free water was then added directly to
the columns and centrifuged for 1 minute at 10,000 RPM. After centrifuge
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samples were stored.
Quantitative Polymerase Chain Reaction (qPCR)
Quantitative PCR was utilized to determine gene expression of the following
genes: ZO-1, claudin-5, occludin, ICAM-1 and TNF-α. All primers were acquired
from Thermo Fisher. A master mix was created with taqman (Life Technologies).
A total volume of 8µL of master mix was added first to the plate followed by 2µL
of cDNA from the brain tissue. After addition of master mix and cDNA, the plate
was centrifuge for 2 minutes at 2000 rpm. The plates were run for three hours in
the light cycler. To calculate a possible change in gene transcription, the deltadelta Ct method was used compared to housekeeping gene.
Statistical Methods
ECIS data were analyzed by a two-way ANOVA with tukey’s posthoc testing to
identify temporal regions of difference among groups. For qPCR statistic analysis
were measured using two-tailed Student’s t-test or one-way ANOVA. The pvalues <0.05 are considered to be statistically significant. GraphPad Prism 7.0
software was utilized for all statistical analyses.
RESULTS
Vanadium containing compounds increase cerebral vascular endothelial
cell resistance
We exposed confluent primary murine cerebrovascular endothelial cells to
different vanadium containing compounds: vanadyl sulfate, vanadium pentoxide
and ammonium metavanadate. We first exposed the cells to vanadyl sulfate and
noticed an increase in electrical resistance at specific doses. The endothelial
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cells treated with vanadyl sulfate at 0.01mM and 0.03mM doses constantly held a
greater resistance compared to control cells treated with media for 24 hours. At a
higher concentration of vanadyl sulfate 0.3mM, the electrical resistance was
higher compared to control for 5 hours and for the remaining of the 24 hours the
resistance decreased in cells treated with vanadyl sulfate (Figure 1). To verify
that vanadium in other forms would have the same effect, cerebrovascular
endothelial cells were also exposed to vanadium pentoxide and ammonium
metavanadate. Endothelial cells treated with 0.01mM and 0.003mM of vanadium
pentoxide demonstrated to have a constant increase in resistance for 24 hours
compared to control cells. Vanadium pentoxide at a dose of 0.1mM and 0.3mM
consistently decreased resistance over 24 hours (Figure 2). Endothelial cells
were also exposed to ammonium metavanadate and at a dose of 0.03mM,
treated cells show constantly higher resistance for 24 hours compared to control
endothelial cells. Ammonium metavanadate at 0.3mM decreased the electrical
resistance over 24 hours (Figure 3). All three different forms of vanadium were
able to consistently increase the electrical resistance over time at lower doses
compared to the control endothelial cells. At higher doses all three vanadiumcontaining compounds decreased the electrical resistance of cerebral vascular
endothelial cells
Vanadyl sulfate does not cause oxidative stress
Vanadium compounds have been associated with an increase in reactive oxygen
species. Tempol is an antioxidant that is used in studies to decreased reactive
oxygen species. In human vein umbilical endothelial cells the addition of tempol
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to arsenite exposed cells leads to a decrease in permeability (Bao et al, 2010).
To test whether different doses of vanadyl sulfate increase reactive oxygen
species, we decided to add tempol, an antioxidant, to vanadium treated
endothelial cells. Cerebral vascular endothelial cells exposed to 1mM of tempol
had a constant decreased in resistance compared to control. The combined
addition of tempol 1mM and vanadyl sulfate 0.03mM lead to a decrease in
resistance 5 hours after the addition of the treatment. The addition of tempol
1mM and vanadyl sulfate 0.1mM also lead to a decrease in resistance 10 hours
after the treatment. When tempol 1mM and vanadyl sulfate 0.3mM are combined
the cells resistance consistently decreases over 24 hours. We observed that the
addition of tempol did not increase BBB permeability at our low and high doses of
vanadium (figure 4). When the different concentrations of vanadium sulfate
0.03mM, 0.1mM, and 0.3mM are combined with tempol 1mM the decreased in
resistance is dose dependent over 24 hours.
Vanadyl sulfate does not inhibit rho kinases
Vanadium containing compounds can have contractile effects that involve the
activation of rho kinases (Ito et al 2015, Mori et al 2004). Rho kinases play a vital
role in the organization of the actin cytoskeleton. RhoA effects on the
cytoskeleton also control cell-cell adhesion (Shi et al, 2013). Rho kinaes can not
only phosphorylate the cytoskeleton but also tight junction proteins leading to an
increase in endothelial cell permeability (Jiang et al, 2018). To evaluate if vanadyl
sulfate activate rho kinases and decreased BBB permeability, fasudil, a welldocumented and known rho kinase inhibitor, was added to vanadium treated
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endothelial cells and electrical resistance was measured. The addition of fasudil
(20µM) to cerebral vascular endothelial cells consistently decreased the cells
resistance over 24 hours. The combination of vanadyl sulfate 0.03mM and fasudil
at 20µM decreased endothelial cell electrical resistance over 24 hours compared
to media control endothelial cells. The addition of vanadyl sulfate 0.1mM plus
fasudil also consistently decreased the resistance over 24 hours as did the
combination of vanadyl sulfate 0.3mM and fasudil. A decrease in resistance is
dependent on the concentration of vanadyl sulfate with 0.3mM concentration
having the largest decrease and 0.003mM of vanadyl sulfate resulting in the
lowest decrease in resistance. The addition of fasudil did not increase endothelial
cell resistance (figure 5).
Vanadyl sulfate does not increase pro-inflammatory factors
Pro-inflammatory factors have been linked to BBB dysfunction and vanadium has
been shown to increase inflammatory factors in specific settings. To test whether
low doses of systemically-administered vanadium could alter pro-inflammatory
factors in the brain, mice were injected IP with vanadium and qPCR was
conducted to measure inflammatory gene transcription levels in the frontal
cortex. No significant difference was observed in the gene transcription levels of
TNF-α (Figure 8) and ICAM-1 (Figure 7) in mice exposed to 0.025mg vanadium
or 0.25mg vanadium as compared to control mice treated with saline.
Vanadyl sulfate increases tight junction protein occludin
We demonstrated that three different vanadium-containing compounds increased
the electrical resistance across a monolayer of murine cerebrovascular
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endothelial cells. Tight junction proteins and the cytoskeleton of brain endothelial
cells are involved in the regulation of barrier integrity. Any changes to tight
junction proteins can have a structural effect on the cytoskeleton as these
proteins form bonds with proteins of the cytoskeleton such as actin. Studies have
demonstrated that an increase in tight junctions such as claudin-5 leads to
enhanced barrier function (Jiang et al, 2018) To investigate if vanadium has an
effect on tight junction protein gene expression, mRNA levels were measured for
the tight junction proteins ZO-1, claudin-5 and occludin. Mice treated with
0.025mg of vanadyl sulfate had significantly increased transcription levels of
occludin (Figure 9). While the levels of ZO-1 (Figure 10) and claudin-5 (Figure
11) remained unchanged compared to the control group with 0.025mg and 0.25
mg of vanadyl sulfate
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Figure 1. Murine cerebral vascular endothelial cells resistance with vanadyl
sulfate using ECIS. Endothelial cells were grown to confluence and treated with
different concentrations of vanadyl sulfate. Each concentration of vanadyl sulfate
including control groups treated with media were run in triplicates. Vanadyl
sulfate 0.01mM and 0.03mM consistently increased resistance for 24 hours.
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Figure 2. Murine cerebral vascular endothelial cells resistance with
vanadium pentoxide using ECIS. Endothelial cells were grown to confluence
and treated with different concentrations of vanadyl sulfate. Each concentration
of vanadium pentoxide including control groups treated with media were run in
triplicates. Vanadium pentoxide 0.01mM and 0.003mM consistently increased
resistance for 24 hours.
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Figure 3. Murine cerebral vascular endothelial cells electrical resistance
with ammonium metavanadate using ECIS. Endothelial cells were grown to
confluence and treated with different concentrations of ammonium metavanadate
and vanadyl sulfate. Each concentration including control groups treated with
media were run in triplicates. Vanadium metavanadate 0.03mM consistently
increased resistance for 24 hours.
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Figure 4. Murine cerebral vascular endothelial cells electrical resistance
with tempol and vanadyl sulfate using ECIS. Endothelial cells were grown to
confluence and treated with tempol 1mM and different concentrations of vanadyl
sulfate. Each concentration including control groups treated with media were run
in triplicates. The addition of tempol to vanadyl sulfate 0.03mM, 0.1mM and
0.3mM decreased the resistance of the endothelial cells in a dose dependent
matter with higher doses of vanadyl sulfate leading to an increase in resistance
over 24 hours.
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Figure 5. Murine cerebral vascular endothelial cells electrical resistance
with fasudil and vanadyl sulfate using ECIS. Endothelial cells were grown to
confluence and treated with fasudil 20µM and different concentrations of vanadyl
sulfate. Each concentration including control groups treated with media were run
in triplicates. The addition of fasudil to vanadyl sulfate 0.03mM, 0.1mM and
0.3mM decreased the resistance of the endothelial cells in a dose dependent
matter with higher doses of vanadyl sulfate leading to an increase in resistance
over 24 hours.
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Figure 6 a-c. Area under the curve (AUC) summations for the tempol (A) and
fasudil (B) permutations. AUC values were determined based on the differences
between the VOSO4 responses at each dose compared to each dose with tempol
or fasudil present. Each AUC plot presents the response from 0-10h and 0-48h,
as we suspect different cellular mechanisms may be at play. Increasing doses of
VOSO4 appear to create a greater tempol-sensitive response, especially in the
10h timeframe. Fasudil did not seem to have such an effect. (C) The role of
VOSO4 in stimulating calcium release was also assessed (n=3/group), in the
presence and absence of tempol and fasudil, but no permutation made a
significant impact on intracellular calcium flux.
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Figure 7. In vivo ICAM frontal brain cortex qPCR gene transcription levels
of vanadium exposed mice. Mice were exposed to vanadyl sulfate (low dose:
0.025mg, 0.25mg high dose) via IP injection twice a day. Animals were sacrificed
after 24 hours of vanadyl sulfate exposure. Control mice received saline IP
injections twice a day. The control group contained an n=4, low vanadium group
n=5, and high vanadium group n=5. No significant difference was observed
(p>0.05) using one-way ANOVA between saline and vanadium treatment groups
for ICAM mRNA levels.
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Figure 8. In vivo TNF-α frontal brain cortex qPCR gene transcription levels
of vanadium exposed mice. Mice were exposed to vanadyl sulfate (low dose:
0.025mg, 0.25mg high dose) via IP injection twice a day. Animals were sacrificed
after 24 hours of vanadyl sulfate exposure. Control mice received saline IP
injections twice a day. The control group contained an n=4, low vanadium group
n=5, and high vanadium group n=5. No significant difference was observed
(p>0.05) using one-way ANOVA between saline and vanadium treatment groups
for TNF-α mRNA levels.
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Figure 9. In vivo occludin frontal brain cortex qPCR gene transcription
levels of vanadium exposed mice. Mice were exposed to vanadyl sulfate (low
dose: 0.025mg, 0.25mg high dose) via IP injection twice a day. Animals were
sacrificed after 24 hours of vanadyl sulfate exposure. Control mice received
saline IP injections twice a day. The control group contained an n=4, low
vanadium group n=5. A significant difference was observed (p<0.05) using twotailed Student’s t-test between saline and low vanadium treatment groups for
occludin mRNA levels.
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Figure 10. In vivo ZO-1 frontal brain cortex qPCR gene transcription levels
of vanadium exposed mice. Mice were exposed to vanadyl sulfate (low dose:
0.025mg, 0.25mg high dose) via IP injection twice a day. Animals were sacrificed
after 24 hours of vanadyl sulfate exposure. Control mice received saline IP
injections twice a day. Saline group contained an n=4, low vanadium group n=5
and high vanadium group n=5. No significant difference was observed (p>0.05)
using one-way ANOVA between saline and low and high vanadium treatment
groups for ZO-1 mRNA levels.
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Figure 11. In vivo claudin-5 frontal brain cortex gene transcription levels of
vanadium exposed mice. Mice were exposed to vanadyl sulfate (low dose:
0.025mg, 0.25mg high dose) via IP injection twice a day. Animals were sacrificed
after 24 hours of vanadyl sulfate exposure. Control mice received saline IP
injections twice a day. The control group contained an n=4, low vanadium group
n=5 and high vanadium group n=3. No significant difference was observed
(p>0.05) using one-way ANOVA between saline and low and high vanadium
treatment groups for claudin-5 mRNA levels.
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Chapter 3. Discussion
This study identifies vanadyl sulfate as a possible therapeutic agent in
BBB disruption. Or, perhaps more conservatively, these results suggest that the
mechanism of action of vanadium – as yet uncertain – may provide a novel path
towards BBB improvement in cerebrovascular disease. Our results show
vanadyl sulfate increases electrical resistance in murine cerebrovascular
endothelial cells. The addition of tempol and fasudil partially abrogated the
enhanced electrical resistance from vanadyl sulfate exposure in endothelial cells.
In mouse studies, intraperitoneal vanadyl sulfate injections did not alter proinflammatory factors TNF-α and ICAM-1. In fact, while underpowered, ICAM-1
expression may have been reduced, suggesting an anti-inflammatory effect of
vanadium at this dose. A possible mechanism by which vanadyl sulfate is
increasing electrical resistance is by increasing the tight junction protein occludin.
Our results also show that vanadyl sulfate does not alter the mRNA for tight
junction proteins claudin-5 and ZO-1.
The literature for vanadium mainly emphasizes its toxicologic effects, with
less research done on investigating possible therapeutic benefits. The chemistry
of vanadium has been related to the formation of intracellular reactive oxygen
species (ROS). It is believed that the conversion of vanadate (V) to vanadyl (IV)
inside cells can generate oxygen radicals and hydrogen peroxide (Capella et al,
2002). Other studies have associated vanadium with the generation of oxidative
stress leading to lipid peroxidation that consequently affects neurons (Todorich et
al, 2011). In this study, we demonstrate that the addition of tempol, a well-used
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antioxidant, antagonized the vanadium-induced electrical resistance of cerebral
vascular endothelial cells in our ECIS experiment. This suggests that at least a
portion of the seemingly beneficial effect of vanadium does relate to the
generation of ROS. Studies use tempol to combat the effects of generating ROS
from agents such as arsenic, another metal that can decrease brain permeability
(Bao et al, 2010). In our experiments, tempol did not increase the resistance of
endothelial cells treated with different concentrations of vanadium suggesting
that vanadyl sulfate was not creating reactive oxygen species (figure 4). Studies
by (Matsubara et al, 1995) suggest that vanadate is an oxyradical scavenger.
Vanadium has been reported as an activator of rho kinases (Ito et al 2015,
Mori et al, 2004). The activation of rho kinases in the BBB brings structural
changes to the cytoskeleton and tight junction proteins (Shi et al 2013, Jiang et
al). Our ECIS in-vitro experiments (figure 5) demonstrate that the addition of
fasudil, a well-documented rho kinase inhibitor, does not have an effect on cells
treated with vanadyl sulfate. This suggests that vanadyl sulfate at the specific
doses used does not disrupt the BBB through phosphorylation of the
cytoskeleton or tight junction proteins. Fasudil is a known rho kinase inhibitor, but
it has also been reported as an MMP inhibitor (Ishiguro et al 2012, Deng et al
2010). The activation of MMPs increases the permeability of the BBB (Reijerkerk
et al, 2006). This could also suggest that vanadyl sulfate is not activating MMPs,
which have been link to disruption of tight junction proteins.
Vanadium has not only been associated with ROS, but also with the
production of pro-inflammatory factors. The BBB can be disrupted when pro-
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inflammatory factors are activated which, in turn, can activate neutrophils (Pun et
al, 2009). Pro-inflammatory factors such as TNF-α and Egr-1 have been
referenced as BBB disruptors. ROS can also indirectly activate ICAM-1 and
VCAM-1 (Kim et al, 2008). Once ICAM-1 is activated, it can recruit WBC to the
BBB and increase barrier permeability. When we exposed mice to vanadium via
IP injections, the mice exposed to vanadyl sulfate did not have an increase in
pro-inflammatory factors TNF-α and ICAM-1. This advocates for the idea that
vanadium can be toxic depending on dose and length of exposure.
Tight junction proteins play a vital role in the regulation of electrical
resistance in BBB endothelial cells. Tight junction protein disruption is associated
with a decrease in BBB resistance. The data from figures 9-11 demonstrate that
vanadyl sulfate does not decrease tight junction proteins. Vanadyl sulfate
exposure increased the tight junction protein occludin, which is one of the
possible mechanisms by which vanadium increases BBB resistance. Vanadyl
sulfate at the appropriate dose has been indicated to be therapeutic and not
toxic. The BBB is an important component of the brain that in many diseases
such as stroke is disrupted. The BBB can increase in permeability when there is
ischemia such as in the case of stroke, but the BBB can also be disrupted by the
stroke treatment tPA. (Zhu et al, 2019). During a stroke, the BBB can be affected
by multiple parameters including but not limited to tight junction proteins
phosphorylation by rho kinases, pro inflammatory factors (TNF-α, interleukin-6)
(Jiang et al 2018), cytoskeleton actin polymerization, (Jiang et al, 2018) and
MMP activation (Rempe et al, 2016). Risk factors to stroke include hypertension
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and diabetes. In hypertension, tight junction protein levels can decrease over
time (Fan et al, 2015) and in diabetes BBB leakage has been documented
(Fujihara et al, 2016). Our studies suggest a potential therapeutic effect of
vanadyl sulfate that highlights novel pathways that could benefit diseases such
as stroke. Moreover, treatment with vanadium may also help control blood
glucose levels in patients with diabetes. In a clinical situation when a patient has
a stroke, high blood glucose levels and receives tPA treatment, vanadyl sulfate
could potentially restore glucose levels and BBB disruption. A more thorough
elucidation of the intracellular pathways contributing to the improvements in
endothelial barrier integrity following vanadium treatment will be needed to
understand such therapeutic pathways.
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